Kerendia Could Be Next Jewel In Bayer's Pharma Crown

 
• By Kevin Grogan
  
Bayer q2 24
Bill Anderson (r) with chief financial officer Wolfgang Nickl • Source: Bayer

More from Earnings

More from Business